Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes From a Multicenter Randomized Controlled Trial
Huashan Liu,Ziwei Zeng,Hong Zhang,Miao Wu,Dan Ma,Quan Wang,Ming Xie,Qing Xu,Jun Ouyang,Yi Xiao,Yongchun Song,Bo Feng,Qingwen Xu,Yanan Wang,Yi Zhang,Yuantao Hao,Shuangling Luo,Xingwei Zhang,Zuli Yang,Junsheng Peng,Xiaojian Wu,Donglin Ren,Meijin Huang,Ping Lan,Weidong Tong,Mingyang Ren,Jianping Wang,Liang Kang,on behalf of the Chinese Transanal Endoscopic Surgery Collaborative Group,on behalf of the Chinese Transanal Endoscopic Surgery Collaborative (CTESC) Group
DOI: https://doi.org/10.1097/sla.0000000000005523
IF: 13.787
2022-12-29
Annals of Surgery
Abstract:Since the advent of total mesorectal excision (TME) in 1982, 1 the surgical outcomes for rectal cancer have improved significantly. Currently, transabdominal TME with laparoscopic technology (laTME) has become one of the general modalities to manage resectable rectal cancer. 2 However, laTME operating in the confined space of the pelvis is often technically challenging due to several tumor-related and patient-related factors, especially for mid-low rectal cancer. Worse yet, due to the "up-to-bottom" technical hurdles, radical resection following laTME is not always guaranteed; difficult patients are significantly predisposed to suffer suboptimal TME or resection margin involvement. These pitfalls highlight an unmet clinical need to develop an optimal approach for rectal cancer surgery.
surgery